mianserin has been researched along with MS (Multiple Sclerosis) in 2 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McGuire, JL | 1 |
Fridman, V | 1 |
Wüthrich, C | 1 |
Koralnik, IJ | 1 |
Jacobs, D | 1 |
Goldstraw, PW | 1 |
Hanna, N | 1 |
Moyes, HC | 1 |
2 other studies available for mianserin and MS (Multiple Sclerosis)
Article | Year |
---|---|
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive | 2011 |
Mianserin and jaundice.
Topics: Adult; Cholestasis; Depression; Dibenzazepines; Female; Humans; Mianserin; Multiple Sclerosis | 1983 |